572 related articles for article (PubMed ID: 16258735)
21. Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes.
Van Campenhout A; Van Campenhout C; Lagrou A; Manuel-y-Keenoy B
Biometals; 2008 Apr; 21(2):159-70. PubMed ID: 17585373
[TBL] [Abstract][Full Text] [Related]
22. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues.
Zengin E; Atukeren P; Kokoglu E; Gumustas MK; Zengin U
Clin Neurol Neurosurg; 2009 May; 111(4):345-51. PubMed ID: 19117666
[TBL] [Abstract][Full Text] [Related]
23. Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients.
Sozer V; Korkmaz Guntas G; Konukoglu D; Dervisoglu E; Gelisgen R; Tabak O; Kalender B; Uzun H
Minerva Med; 2013 Feb; 104(1):75-84. PubMed ID: 23392540
[TBL] [Abstract][Full Text] [Related]
24. Diabetes, oxidative stress, and antioxidants: a review.
Maritim AC; Sanders RA; Watkins JB
J Biochem Mol Toxicol; 2003; 17(1):24-38. PubMed ID: 12616644
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
26. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress and the development of diabetic complications--antioxidants and lipid peroxidation in erythrocytes and cell membrane.
Parthiban A; Vijayalingam S; Shanmugasundaram KR; Mohan R
Cell Biol Int; 1995 Dec; 19(12):987-93. PubMed ID: 9721623
[TBL] [Abstract][Full Text] [Related]
28. Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis.
Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
Nephrol Dial Transplant; 2008 May; 23(5):1697-703. PubMed ID: 18174265
[TBL] [Abstract][Full Text] [Related]
29. Lipid peroxidation and catalase in diabetes mellitus with and without ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M; Lazăr L; Drută A
Rom J Intern Med; 2004; 42(2):423-9. PubMed ID: 15529632
[TBL] [Abstract][Full Text] [Related]
30. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
[TBL] [Abstract][Full Text] [Related]
31. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S
Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219
[TBL] [Abstract][Full Text] [Related]
32. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant markers in human senile and diabetic cataractous lenses.
Hashim Z; Zarina S
J Coll Physicians Surg Pak; 2006 Oct; 16(10):637-40. PubMed ID: 17007750
[TBL] [Abstract][Full Text] [Related]
34. Evidence that 3-hydroxy-3-methylglutaric acid promotes lipid and protein oxidative damage and reduces the nonenzymatic antioxidant defenses in rat cerebral cortex.
Leipnitz G; Seminotti B; Haubrich J; Dalcin MB; Dalcin KB; Solano A; de Bortoli G; Rosa RB; Amaral AU; Dutra-Filho CS; Latini A; Wajner M
J Neurosci Res; 2008 Feb; 86(3):683-93. PubMed ID: 17941049
[TBL] [Abstract][Full Text] [Related]
35. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
36. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
Pan HZ; Zhang H; Chang D; Li H; Sui H
Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
[TBL] [Abstract][Full Text] [Related]
37. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
Chaudhry J; Ghosh NN; Roy K; Chandra R
Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
[TBL] [Abstract][Full Text] [Related]
38. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus.
Kuppusamy UR; Indran M; Ahmad T; Wong SW; Tan SY; Mahmood AA
Clin Chim Acta; 2005 Jan; 351(1-2):197-201. PubMed ID: 15563890
[TBL] [Abstract][Full Text] [Related]
39. Markers of oxidative stress in the skeletal muscle of patients on haemodialysis.
Crowe AV; McArdle A; McArdle F; Pattwell DM; Bell GM; Kemp GJ; Bone JM; Griffiths RD; Jackson MJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1177-83. PubMed ID: 17213227
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
